153 related articles for article (PubMed ID: 17716893)
1. Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies.
Mugnaini C; Rajamaki S; Tintori C; Corelli F; Massa S; Witvrouw M; Debyser Z; Veljkovic V; Botta M
Bioorg Med Chem Lett; 2007 Oct; 17(19):5370-3. PubMed ID: 17716893
[TBL] [Abstract][Full Text] [Related]
2. Efficient 3D database screening for novel HIV-1 IN inhibitors.
Barreca ML; Rao A; De Luca L; Zappalà M; Gurnari C; Monforte P; De Clercq E; Van Maele B; Debyser Z; Witvrouw M; Briggs JM; Chimirri A
J Chem Inf Comput Sci; 2004; 44(4):1450-5. PubMed ID: 15272853
[TBL] [Abstract][Full Text] [Related]
3. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
Hong H; Neamati N; Wang S; Nicklaus MC; Mazumder A; Zhao H; Burke TR; Pommier Y; Milne GW
J Med Chem; 1997 Mar; 40(6):930-6. PubMed ID: 9083481
[TBL] [Abstract][Full Text] [Related]
4. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
[TBL] [Abstract][Full Text] [Related]
5. A versatile and practical synthesis toward the development of novel HIV-1 integrase inhibitors.
Rinaldi M; Tintori C; Franchi L; Vignaroli G; Innitzer A; Massa S; Esté JA; Gonzalo E; Christ F; Debyser Z; Botta M
ChemMedChem; 2011 Feb; 6(2):343-52. PubMed ID: 21246739
[TBL] [Abstract][Full Text] [Related]
6. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
[TBL] [Abstract][Full Text] [Related]
7. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
8. De novo design and synthesis of HIV-1 integrase inhibitors.
Makhija MT; Kasliwal RT; Kulkarni VM; Neamati N
Bioorg Med Chem; 2004 May; 12(9):2317-33. PubMed ID: 15080929
[TBL] [Abstract][Full Text] [Related]
9. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
Bhatt H; Patel P; Pannecouque C
Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
[TBL] [Abstract][Full Text] [Related]
10. Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors.
Meadows DC; Tantillo DJ; Gervay-Hague J
ChemMedChem; 2006 Sep; 1(9):959-64. PubMed ID: 16952140
[No Abstract] [Full Text] [Related]
11. Novel virtual screening protocol based on the combined use of molecular modeling and electron-ion interaction potential techniques to design HIV-1 integrase inhibitors.
Tintori C; Manetti F; Veljkovic N; Perovic V; Vercammen J; Hayes S; Massa S; Witvrouw M; Debyser Z; Veljkovic V; Botta M
J Chem Inf Model; 2007; 47(4):1536-44. PubMed ID: 17608406
[TBL] [Abstract][Full Text] [Related]
12. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
Garofalo A; Grande F; Brizzi A; Aiello F; Dayam R; Neamati N
ChemMedChem; 2008 Jun; 3(6):986-90. PubMed ID: 18383063
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel tricyclic HIV-1 integrase inhibitors by modification of its pyridine ring.
Metobo SE; Jin H; Tsiang M; Kim CU
Bioorg Med Chem Lett; 2006 Aug; 16(15):3985-8. PubMed ID: 16723226
[TBL] [Abstract][Full Text] [Related]
14. Mining the NCI antiviral compounds for HIV-1 integrase inhibitors.
Deng J; Kelley JA; Barchi JJ; Sanchez T; Dayam R; Pommier Y; Neamati N
Bioorg Med Chem; 2006 Jun; 14(11):3785-92. PubMed ID: 16460953
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors.
Langford HM; Williams PD; Homnick CF; Vacca JP; Felock PJ; Stillmock KA; Witmer MV; Hazuda DJ; Gabryelski LJ; Schleif WA
Bioorg Med Chem Lett; 2008 Jan; 18(2):721-5. PubMed ID: 18078751
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
Li X; Vince R
Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300
[TBL] [Abstract][Full Text] [Related]
17. 6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays.
Costi R; Di Santo R; Artico M; Roux A; Ragno R; Massa S; Tramontano E; La Colla M; Loddo R; Marongiu ME; Pani A; La Colla P
Bioorg Med Chem Lett; 2004 Apr; 14(7):1745-9. PubMed ID: 15026063
[TBL] [Abstract][Full Text] [Related]
18. Development of a receptor model for efficient in silico screening of HIV-1 integrase inhibitors.
Quevedo MA; Ribone SR; Briñón MC; Dehaen W
J Mol Graph Model; 2014 Jul; 52():82-90. PubMed ID: 25023663
[TBL] [Abstract][Full Text] [Related]
19. Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones.
Gardelli C; Nizi E; Muraglia E; Crescenzi B; Ferrara M; Orvieto F; Pace P; Pescatore G; Poma M; Ferreira Mdel R; Scarpelli R; Homnick CF; Ikemoto N; Alfieri A; Verdirame M; Bonelli F; Paz OG; Taliani M; Monteagudo E; Pesci S; Laufer R; Felock P; Stillmock KA; Hazuda D; Rowley M; Summa V
J Med Chem; 2007 Oct; 50(20):4953-75. PubMed ID: 17824681
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel HIV-1 integrase inhibitor from natural compounds through structure based virtual screening and cell imaging.
Gu WG; Zhang X; Ip DT; Yang LM; Zheng YT; Wan DC
FEBS Lett; 2014 Sep; 588(18):3461-8. PubMed ID: 25128456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
